Pfizer said on April 22 the company was voluntarily recalling five batches of Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

The BA.2 sub-variant of Omicron was estimated to be 23.1 percent of the coronavirus variants circulating in the United States as of March 12, the U.S. Centers for Disease Control and Prevention (CDC) said on March 15.

New cases of Covid-19 in the United States fell for a fourth week in a row – dropping 17 percent in the week ended May 9 to just under 290,000 – the lowest weekly total since September, according to a Reuters analysis of state and county data.

Walmart Inc. is preparing to offer Covid-19 vaccinations in seven more states, as well as in Chicago and Puerto Rico, expanding beyond the two states where the company’s pharmacists are offering inoculations.

The United States recorded more than 15,000 deaths from Covid-19 and over 1.2 million new cases for the week ended Dec. 27, though those numbers may be artificially low due to reporting gaps over the Christmas holiday.

The U.S. FDA gave Sanofi SA’s dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine can cause severe infections in some people.

New York state sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic.

The U.S. FDA expects a shortage of intravenous saline fluids for hospitals due to damage to key manufacturing facilities in Puerto Rico to improve over the coming weeks and months.

In terms of acquisitions, the company is looking to expand its immunology pipeline as well as oncology.

The U.S. House of Representatives approved legislation to continue a federal insurance program for millions of lower-income children and pregnant women, but with an ongoing funding battle it could be weeks before the program gets more money.